Similar results were obtained in a subgroup of GBM patients (n = 6) showing complete loss of TRPV1v3 mRNA expression, as respect to TRPV1 expressing GBM patients (n = 38) (p = 0.0006) (Figure 4B and Table 4B). The gene discussed is TRPV1; the disease is glioblastoma.